로딩 중…
지수 로딩 중…
Intellia Therapeutics, Inc.
NTLA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$15.67+3.09%
2026-06-18
Price Chart
Intellia Therapeutics, Inc.+63.23%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.19B |
| Revenue | $66M |
| Net Income | $-395M |
| Total Assets | $759M |
| Net Assets | $621M |
| Value | |
| P/B | 3.53x |
| P/S | 33.13x |
| FCF Yield | -16.61% |
| Profitability | |
| ROE | -63.55% |
| ROA | -52.00% |
| Op. Margin | -636.56% |
| Revenue Growth | -9.50% |
| Financial Health | |
| Debt Ratio | 22.20% |
| Total Debt | $80M |
| FCF | $-364M |
| Cash | $135M |
| Current Ratio | 6.10x |
| Performance | |
| 1Y Return | 63.23% |
| 1M Return | 31.24% |
| From 52W High | -44.53% |
| 1Y MDD | -71.27% |
| Trading | |
| Volume | 7,496,051 shares |
| Trading Value | $117M |
| Per Share | |
| EPS | $-3.81 |
| BPS | $6.20 |